Janus Living, Inc.
No enriched coverage for $JAN in the last 7 days.
No SEC Form 4 filings for $JAN in the last 30 days.
See all $JAN insider activity →Wells Fargo maintained an Overweight rating on Janus Living Inc (JAN) but lowered its price target from $35.00 to $34.00. The company has a high P/E ratio of 3189.44x and a GF Score™ of 14/100, indicating challenges in profitability and growth despite a strong balance sheet. JAN operates in the senior housing REIT sector.
Priority Life Care and Almanac acquired seven senior living communities in Pennsylvania. Janus Living (JAN) secured a $1.25B credit facility. ESI sold a four-property portfolio for $200M. Walker & Dunlop closed $30M in LIHTC for a Texas affordable senior housing project. Embrace Living expanded by managing Brementowne Manor Senior Apartments.
Healthpeak Properties (DOC) raised its 2026 guidance, citing strong performance in outpatient medical and lab leasing, and significant growth at its senior housing operator, Janus Living (JAN). The company reported $0.46 FFO per share, flat year-over-year, and used asset sales to reduce debt and fund buybacks. Lab segment NOI declined, and leverage remains at 4.7x EBITDAre.
Recent JAN coverage spans corporate actions, earnings and financial news.
Analyst target cut signals modest downside risk.
The new credit line enhances liquidity and may support further acquisitions, potentially boosting the REIT's valuation.
Strong performance of the senior‑housing subsidiary adds to Healthpeak’s growth narrative.
The larger credit line improves liquidity and may support growth initiatives, potentially boosting the stock.
The filing discloses a new equity offering structure, which can pressure near-term price via dilution risk and float expansion.
AlphAI scores every news story that mentions JAN with an AI model for sentiment and relevance, and aggregates insider trades from Janus Living, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Wells Fargo maintained an Overweight rating on Janus Living Inc (JAN) but lowered its price target from $35.00 to $34.00. The company has a high P/E ratio of 3189.44x and a GF Score™ of 14/100, indicating challenges in profitability and growth despite a strong balance sheet. JAN operates in the senior housing REIT sector.
1 min readPriority Life Care and Almanac acquired seven senior living communities in Pennsylvania. Janus Living (JAN) secured a $1.25B credit facility. ESI sold a four-property portfolio for $200M. Walker & Dunlop closed $30M in LIHTC for a Texas affordable senior housing project. Embrace Living expanded by managing Brementowne Manor Senior Apartments.
2 min readHealthpeak Properties (DOC) raised its 2026 guidance, citing strong performance in outpatient medical and lab leasing, and significant growth at its senior housing operator, Janus Living (JAN). The company reported $0.46 FFO per share, flat year-over-year, and used asset sales to reduce debt and fund buybacks. Lab segment NOI declined, and leverage remains at 4.7x EBITDAre.
3 min readJanus Living, Inc. (JAN) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Agreement Credit Facility Amendment On March 23, 2026, Janus Living, Inc. (the “Company”) and Janus Living OP, LLC (the “Operating Company”) entered into a Credit Agreement (the “Original Credit Agreement”), dated as of March 23, 2026, by and among
1 min readJanus Living, Inc. (JAN) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Agreement On August 12, 2026, Janus Living, Inc. (the “Company” and, unless the context otherwise requires, together with its consolidated subsidiaries, “we,” “us,” or “our”) closed its registered underwritten public offering (the “Offering”) of 18
3 min readJanus Living (JAN) shares fell 2.6% in pre-open after the company priced a follow-on offering of 16 million Class A-1 shares at $29.00, below the prior close of $30.18. Underwriters received a 30-day option for up to 2.4 million more shares. Proceeds will fund acquisitions and general purposes, with expected closing Aug. 13, 2026.
3 min readJanus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.
6 min readJanus Living, Inc. (JAN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Janus Living Reports Second Quarter 2026 Results and Increases Full Year 2026 Guidance DENVER, August 4, 2026 - Janus Living, Inc. (NYSE : JAN) (“Janus Living”), a pure-play senior housing real estate investment trust (REIT), announced results fo r the quarter ended
2 min readHealthcare rose more than 6% in June as investors favored defensives over tech. Raymond James refreshed its healthcare top-picks list, adding UnitedHealth Group (UNH) and Janus Living (JAN). UNH is up 28% YTD; Q1 adjusted EPS $7.23 on $111.72B revenue; raised dividend to $2.32. JAN, an REIT, debuted in March IPO at $20 and closed at $28.99; dividend yield 1.96%.
6 min readWall Street analysts issued a range of calls on Wednesday. Bernstein initiated GE Vernova (outperform), NeoVolta (buy, $8 PT) and reiterated Nvidia (outperform). Deutsche Bank raised Micron’s PT to $1,500 ahead of next week’s earnings. Bernstein also lifted AMD to $600, Intel to $100, and Arm to $500. Morgan Stanley downgraded ResMed to equal weight; Citi initiated Figma (buy, $36 PT).
3 min read
